Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysis.

Jiali DaiXinyin LiuJun LiTianyu QuYanan CuiShidai JinErbao ZhangRen-Hua Guo

Published in: Thoracic cancer (2023)

Based on the efficacy and safety, the combination of chemotherapy with EGFR-TKIs is considered the best combination treatment options in advanced NSCLC with EGFR mutation.

Keyphrases

epidermal growth factor receptor
advanced non small cell lung cancer
small cell lung cancer
tyrosine kinase
locally advanced
brain metastases
squamous cell carcinoma
radiation therapy